Simple breathing exercise shows promise for COPD sufferers

NCT ID NCT07001462

Completed Symptom relief Sponsor: Bugra Kerget Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a breathing training device (IMT/PEP) could improve lung function and reduce breathlessness in people with severe, exacerbation-prone COPD. 61 stable patients used the device twice daily for 12 weeks alongside their usual medications. Researchers measured changes in breathing strength, lung volume, exercise capacity, and symptom scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Inspiratory muscle training and positive expiratory pressure (IMT/PEP) therapy using a dual-function breathing device
What this could lead to: If it works, this could offer a simple, at-home breathing exercise to help COPD patients breathe easier and be more active.
What could go wrong: This is a small, completed trial with only 61 patients, so results may not apply to everyone. The therapy is an add-on to standard care, not a replacement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD INSPIRATORY MUSCLE TRAINING

Contacts and locations

Locations

Ataturk University

Erzurum, Yakutiye, 25200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.